Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma
Publication
, Conference
Reardon, DA; Rich, J; Quinn, J; Vredenburgh, J; Desjardins, A; Sathornsumetee, S; Gururangan, S; Lyons, P; Bigner, D; Friedman, H
Published in: NEURO-ONCOLOGY
July 1, 2005
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
312 / 312
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Rich, J., Quinn, J., Vredenburgh, J., Desjardins, A., Sathornsumetee, S., … Friedman, H. (2005). Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma. In NEURO-ONCOLOGY (Vol. 7, pp. 312–312). Edinburgh, SCOTLAND: DUKE UNIV PRESS.
Reardon, D. A., J. Rich, J. Quinn, J. Vredenburgh, A. Desjardins, S. Sathornsumetee, S. Gururangan, P. Lyons, D. Bigner, and H. Friedman. “Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma.” In NEURO-ONCOLOGY, 7:312–312. DUKE UNIV PRESS, 2005.
Reardon DA, Rich J, Quinn J, Vredenburgh J, Desjardins A, Sathornsumetee S, et al. Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 312–312.
Reardon, D. A., et al. “Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma.” NEURO-ONCOLOGY, vol. 7, no. 3, DUKE UNIV PRESS, 2005, pp. 312–312.
Reardon DA, Rich J, Quinn J, Vredenburgh J, Desjardins A, Sathornsumetee S, Gururangan S, Lyons P, Bigner D, Friedman H. Phase I study results of Gefitinib (iressa; ZD1839) plus rapamycin in the treatment of patients with recurrent malignant glioma. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 312–312.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
312 / 312
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences